semaglutide type 1 diabetes randomized trial 2024 Efficacy and safety of oral vs sitagliptin in a predominantly Chinese population with 2 uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised | Diabetologia Summary of the randomized, controlled

In contrast to insulin, however, GLP-1 causes a decrease in body weight [28]

More is not necessarily better when the objective includes maintaining adequate caloric intake for muscle building

The effect of glucagon-like peptide-1 receptor agonists on diabetic retinopathy at a tertiary care center

Insoluble fibre adds bulk to stools and promotes regular bowel movements, which becomes especially relevant given that constipation is a common or very common side effect of GLP-1 drugs, depending on the specific product and dose

Many people describe the first week or two as feeling nearly identical to their last weeks on the medication, followed by a noticeable jump in hunger cues around week three or four